Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial

British Journal of Cancer

Volumn 103, Issue 9, 2010, Pages 1453-1461

  Bobe, G ^a   Murphy, G ^a   Albert, P S ^b   Sansbury, L B ^a   Lanza, E ^a   Schatzkin, A ^a   Colburn, N H ^a   Cross, A J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

cancer prevention; colorectal adenoma; colorectal cancer; cytokines; flavonols

Indexed keywords

CYTOKINE; FLAVONOL; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER PREVENTION; COLORECTAL ADENOMA; DRUG EFFECT; FEMALE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; TUMOR RECURRENCE;

ADENOMA; AGED; CLINICAL TRIALS AS TOPIC; COLORECTAL NEOPLASMS; CYTOKINES; DIET; FEMALE; FLAVONOLS; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; RECURRENCE;

EID: 78049288153     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605915     Document Type: Article

References (81)

1. Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y, Song X, Dvozkin T, Krelin Y, Voronov E (2006) The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 25: 387-408
2. Bandyopadhyay S, Romero JR, Chattopadhyay N (2008) Kaempferol and quercetin stimulate granulocyte-macrophage colony-stimulating factor secretion in human prostate cancer cells. Mol Cell Endocrinol 287: 57-64
3. Bednar W, Holzmann K, Marian B (2007) Assessing 12(S)-lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzyme. Food Chem Toxicol 45: 508-514
4. Berghella AM, Contasta I, Pellegrini P, Del Beato T, Adorno D (2002) Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer. Cancer Biother Radiopharm 17: 43-50
5. Berghella AM, Pellegrini P, Del Beato T, Adorno D, Casciani CU (1997) IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer. Cancer Biother Radiopharm 12: 265-272
6. Berghella AM, Pellegrini P, Del Beato T, Maccarone D, Adorno D, Casciani CU (1996) Prognostic significance of immunological evaluation in colorectal cancer. Cancer Biother Radiopharm 11: 355-361
7. Block G, Hartman AM, Naughton D (1990) A reduced dietary questionnaire: development and validation. Epidemiology 1: 58-64
8. Bobe G, Albert PS, Sansbury LB, Lanza E, Schatzkin A, Colburn NH, Cross AJ (2010) Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial. Cancer Prev Res (Phila Pa) 3: 764-775
9. Bobe G, Sansbury LB, Albert PS, Cross AJ, Kahle L, Ashby J, Slattery ML, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Daston C, Marshall JR, Schatzkin A, Lanza E (2008) Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial. Cancer Epidemiol Biomarkers Prev 17: 1344-1353
10. Boots AW, Drent M, Swennen EL, Moonen HJ, Bast A, Haenen GR (2009) Antioxidant status associated with inflammation in sarcoidosis: a potential role for antioxidants. Respir Med 103: 364-372
11. Boots AW, Wilms LC, Swennen EL, Kleinjans JC, Bast A, Haenen GR (2008) In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition 24: 703-710
12. Caan BJ, Lanza E, Schatzkin A, Coates AO, Brewer BK, Slattery ML, Marshall JR, Bloch A (1999) Does nutritionist review of a self-administered food frequency questionnaire improve data quality? Public Health Nutr 2: 565-569
13. Camuesco D, Comalada M, Concha A, Nieto A, Sierra S, Xaus J, Zarzuelo A, Galvez J (2006) Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis. Clin Nutr 25: 466-476
14. Choi EJ, Bae SM, Ahn WS (2008) Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Arch Pharm Res 31: 1281-1285
15. Chun OK, Chung SJ, Claycombe KJ, Song WO (2008) Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults. J Nutr 138: 753-760
16. Chun OK, Chung SJ, Song WO (2007) Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr 137: 1244-1252
17. Contasta I, Berghella AM, Pellegrini P, Adorno D (2003) Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions. Cancer Biother Radiopharm 18: 549-557
18. Csiszar A, Szentes T, Haraszti B, Balazs A, Petranyi GG, Pocsik E (2004) The pattern of cytokine gene expression in human colorectal carcinoma. Pathol Oncol Res 10: 109-116
19. Cui G, Florholmen J (2008) Polarization of cytokine profile from Th1 into Th2 along colorectal adenoma-carcinoma sequence: implications for the biotherapeutic target? Inflamm Allergy Drug Targets 7: 94-97
20. Duthie SJ, Dobson VL (1999) Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro. Eur J Nutr 38: 28-34
21. Egert S, Boesch-Saadatmandi C, Wolffram S, Rimbach G, Muller MJ (2010) Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J Nutr 140: 278-284
22. Ferguson LR, Philpott M (2007) Cancer prevention by dietary bioactive components that target the immune response. Curr Cancer Drug Targets 7: 459-464
23. Galizia G, Orditura M, Romano C, Lieto E, Castellano P, Pelosio L, Imperatore V, Catalano G, Pignatelli C, De Vita F (2002) Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin Immunol 102: 169-178
24. Grande C, Firvida JL, Navas V, Casal J (2006) Interleukin-2 for the treatment of solid tumors other than melanoma and renal cell carcinoma. Anticancer Drugs 17: 1-12
25. Guo M, Perez C, Wei Y, Rapoza E, Su G, Bou-Abdallah F, Chasteen ND (2007) Iron-binding properties of plant phenolics and cranberry's bio-effects. Dalton Trans (43): 4951-4961
26. Gupta C, Vikram A, Tripathi DN, Ramarao P, Jena GB (2010) Antioxidant and antimutagenic effect of quercetin against DEN induced hepatotoxi-city in rat. Phytother Res 24: 119-128
27. Huang RY, Yu YL, Cheng WC, OuYang CN, Fu E, Chu CL (2010) Immunosuppressive effect of quercetin on dendritic cell activation and function. J Immunol 184: 6815-6821
28. Ichimatsu D, Nomura M, Nakamura S, Moritani S, Yokogawa K, Kobayashi S, Nishioka T, Miyamoto K (2007) Structure-activity relationship of flavonoids for inhibition of epidermal growth factor-induced transformation of JB6 Cl 41 cells. Mol Carcinog 46: 436-445
29. Jeong JH, An JY, Kwon YT, Rhee JG, Lee YJ (2009) Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression. J Cell Biochem 106: 73-82
30. Kaminska J, Nowacki MP, Kowalska M, Rysinska A, Chwalinski M, Fuksiewicz M, Michalski W, Chechlinska M (2005) Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I-an independent prognostic factor. Tumour Biol 26: 186-194
31. Kanakis CD, Tarantilis PA, Polissiou MG, Diamantoglou S, Tajmir-Riahi HA (2007) An overview of DNA and RNA bindings to antioxidant flavonoids. Cell Biochem Biophys 49: 29-36
32. Kim JD, Liu L, Guo W, Meydani M (2006) Chemical structure of flavonols in relation to modulation of angiogenesis and immune-endothelial cell adhesion. J Nutr Biochem 17: 165-176
33. Kim S, Keku TO, Martin C, Galanko J, Woosley JT, Schroeder JC, Satia JA, Halabi S, Sandler RS (2008) Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res 68: 323-328
34. Kim WK, Bang MH, Kim ES, Kang NE, Jung KC, Cho HJ, Park JH (2005) Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells. J Nutr Biochem 16: 155-162
35. Kimura S, Warabi E, Yanagawa T, Ma D, Itoh K, Ishii Y, Kawachi Y, Ishii T (2009) Essential role of Nrf2 in keratinocyte protection from UVA by quercetin. Biochem Biophys Res Commun 387: 109-114
36. Krelin Y, Voronov E, Dotan S, Elkabets M, Reich E, Fogel M, Huszar M, Iwakura Y, Segal S, Dinarello CA, Apte RN (2007) Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res 67: 1062-1071
37. Kwon KH, Murakami A, Tanaka T, Ohigashi H (2005) Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem Pharmacol 69: 395-406
38. Lam TK, Rotunno M, Lubin JH, Wacholder S, Consonni D, Pesatori AC, Bertazzi PA, Chanock SJ, Burdette L, Goldstein AM, Tucker MA, Caporaso NE, Subar AF, Landi MT (2010) Dietary quercetin, quercetin-gene interaction, metabolic gene expression in lung tissue and lung cancer risk. Carcinogenesis 31: 634-642
39. Lanza E, Schatzkin A, Daston C, Corle D, Freedman L, Ballard-Barbash R, Caan B, Lance P, Marshall J, Iber F, Shike M, Weissfeld J, Slattery M, Paskett E, Mateski D, Albert P (2001) Implementation of a 4-y, high-fiber, high-fruit-and-vegetable, low-fat dietary intervention: results of dietary changes in the Polyp Prevention Trial. Am J Clin Nutr 74: 387-401
40. Lee KM, Hwang MK, Lee DE, Lee KW, Lee HJ (2010a) Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells. J Agric Food Chem 58: 5815-5820
41. Lee KM, Lee KW, Byun S, Jung SK, Seo SK, Heo YS, Bode AM, Lee HJ, Dong Z (2010b) 5-deoxykaempferol plays a potential therapeutic role by targeting multiple signaling pathways in skin cancer. Cancer Prev Res (Phila Pa) 3: 454-465
42. Lee KW, Kang NJ, Heo YS, Rogozin EA, Pugliese A, Hwang MK, Bowden GT, Bode AM, Lee HJ, Dong Z (2008) Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res 68: 946-955
43. Lee YJ, Suh KS, Choi MC, Chon S, Oh S, Woo JT, Kim SW, Kim JW, Kim YS (2010c) Kaempferol protects HIT-T15 pancreatic beta cells from 2-deoxy-D-ribose-induced oxidative damage. Phytother Res 24: 419-423
44. Lian TW, Wang L, Lo YH, Huang IJ, Wu MJ (2008) Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages. Biochim Biophys Acta 1781: 601-609
45. Lim JH, Park JW, Min DS, Chang JS, Lee YH, Park YB, Choi KS, Kwon TK (2007) NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells. Apoptosis 12: 411-421
46. Lin CW, Hou WC, Shen SC, Juan SH, Ko CH, Wang LM, Chen YC (2008) Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1- dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 29: 1807-1815
47. Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117: 1175-1183
48. Luo H, Rankin GO, Liu L, Daddysman MK, Jiang BH, Chen YC (2009) Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr Cancer 61: 554-563
49. Miki C, Tonouchi H, Wakuda R, Hatada T, Inoue Y, Minato E, Kobayashi M, Kusunoki M (2002) Intra-tumoral interleukin-6 down-regulation system and genetic mutations of tumor suppressor genes in colorectal carcinoma. Cancer 94: 1584-1592
50. Min K, Ebeler SE (2009) Quercetin inhibits hydrogen peroxide-induced DNA damage and enhances DNA repair in Caco-2 cells. Food Chem Toxicol 47: 2716-2722
51. Min YD, Choi CH, Bark H, Son HY, Park HH, Lee S, Park JW, Park EK, Shin HI, Kim SH (2007) Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm Res 56: 210-215
52. Moon H, Choi HH, Lee JY, Moon HJ, Sim SS, Kim CJ (2008) Quercetin inhalation inhibits the asthmatic responses by exposure to aerosolized-ovalbumin in conscious guinea-pigs. Arch Pharm Res 31: 771-778
53. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765
54. Mroczko B, Szmitkowski M, Okulczyk B, Piotrowski Z (2001) Granulocyte-macrophage-colony stimulating factor in patients with colorectal cancer. Folia Histochem Cytobiol 39(Suppl 2): 110-111
55. Mroczko B, Szmitkowski M, Wereszczynska-Siemiatkowska U, Okulczyk B, Kedra B (2007) Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer. Int J Colorectal Dis 22: 33-38
56. Nair MP, Kandaswami C, Mahajan S, Chadha KC, Chawda R, Nair H, Kumar N, Nair RE, Schwartz SA (2002) The flavonoid, quercetin, differentially regulates Th-1 (IFNgamma) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells. Biochim Biophys Acta 1593: 29-36
57. Nieman DC, Henson DA, Gross SJ, Jenkins DP, Davis JM, Murphy EA, Carmichael MD, Dumke CL, Utter AC, McAnulty SR, McAnulty LS, Mayer EP (2007) Quercetin reduces illness but not immune perturbations after intensive exercise. Med Sci Sports Exerc 39: 1561-1569
58. Okoko T, Oruambo IF (2009) Inhibitory activity of quercetin and its metabolite on lipopolysaccharide-induced activation of macrophage U937 cells. Food Chem Toxicol 47: 809-812
59. Ordemann J, Jacobi CA, Braumann C, Schwenk W, Volk HD, Muller JM (2002) Immunomodulatory changes in patients with colorectal cancer. Int J Colorectal Dis 17: 37-41
60. Park HH, Lee S, Son HY, Park SB, Kim MS, Choi EJ, Singh TS, Ha JH, Lee MG, Kim JE, Hyun MC, Kwon TK, Kim YH, Kim SH (2008) Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch Pharm Res 31: 1303-1311
61. Pellegrini P, Berghella AM, Contasta I, Del Beato T, Adorno D (2006) The study of a patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer. Cancer Biother Radiopharm 21: 443-467
62. Phromnoi K, Yodkeeree S, Anuchapreeda S, Limtrakul P (2009) Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids. Acta Pharmacol Sin 30: 1169-1176
63. Richter M, Ebermann R, Marian B (1999) Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. Nutr Cancer 34: 88-99
64. Roselli M, Guadagni F, Martini F, Spila A, Mariotti S, D'Alessandro R, Aloe S, Gazzaniga PP, Basili S, Cosimelli M, Ferroni P (2003) Association between serum carcinoembryonic antigen and endothelial cell adhesion molecules in colorectal cancer. Oncology 65: 132-138
65. Rossi M, Negri E, Talamini R, Bosetti C, Parpinel M, Gnagnarella P, Franceschi S, Dal Maso L, Montella M, Giacosa A, La Vecchia C (2006) Flavonoids and colorectal cancer in Italy. Cancer Epidemiol Biomarkers Prev 15: 1555-1558
66. Ruf AA, Webb J, Anderson D (2003) Modulation by flavonoids of the effects of a food mutagen in different thalassaemia genotypes in the Comet assay. Teratog Carcinog Mutagen (Suppl 2): 93-102
67. Ruiz PA, Haller D (2006) Functional diversity of flavonoids in the inhibition of the proinflammatory NF-kappaB, IRF, and Akt signaling pathways in murine intestinal epithelial cells. J Nutr 136: 664-671
68. Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B, Shike M, Weissfeld J, Burt R, Cooper MR, Kikendall JW, Cahill J (2000) Lack of effect of alow-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 342: 1149-1155
69. Schetter AJ, Nguyen GH, Bowman ED, Mathe EA, Yuen ST, Hawkes JE, Croce CM, Leung SY, Harris CC (2009) Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res 15: 5878-5887
70. Si D, Wang Y, Zhou YH, Guo Y, Wang J, Zhou H, Li ZS, Fawcett JP (2009) Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug Metab Dispos 37: 629-634
71. Stanilov N, Miteva L, Mintchev N, Stanilova S (2009) High expression of Foxp3, IL-23p19 and survivin mRNA in colorectal carcinoma. Int J Colorectal Dis 24: 151-157
72. Theodoratou E, Kyle J, Cetnarskyj R, Farrington SM, Tenesa A, Barnetson R, Porteous M, Dunlop M, Campbell H (2007) Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 16: 684-693
73. Tiong KH, Yiap BC, Tan EL, Ismail R, Ong CE (2010) In vitro modulation of naturally occurring flavonoids on cytochrome P450 2A6 (CYP2A6) activity. Xenobiotica 40: 458-466
74. U.S. Department of Agriculture ARS (2007) USDA database for the flavonoid content of selected foods. In Nutrient Data Laboratory web site: USDA
75. Uronis JM, Muhlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C (2009) Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One 4: e6026
76. Vijayababu MR, Arunkumar A, Kanagaraj P, Venkataraman P, Krishnamoorthy G, Arunakaran J (2006) Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Mol Cell Biochem 287: 109-116
77. Wang L, Tu YC, Lian TW, Hung JT, Yen JH, Wu MJ (2006) Distinctive antioxidant and antiinflammatory effects of flavonols. J Agric Food Chem 54: 9798-9804
78. Wang LS, Stoner GD (2008) Anthocyanins and their role in cancer prevention. Cancer Lett 269: 281-290
79. Wilms LC, Hollman PC, Boots AW, Kleinjans JC (2005) Protection by quercetin and quercetin-rich fruit juice against induction of oxidative DNA damage and formation of BPDE-DNA adducts in human lymphocytes. Mutat Res 582: 155-162
80. Yoon JH, Baek SJ (2005) Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med J 46: 585-596
81. Zhang W, Zhang F (2009) Effects of quercetin on proliferation, apoptosis, adhesion and migration, and invasion of HeLa cells. Eur J Gynaecol Oncol 30: 60-64